PRODUCTS
SERVICES
Investment objective of the scheme is to provide long term capital appreciation by investing in equity & equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.The Scheme does not guarantee/indicate any returns. There can be no assurance that the schemes objectives will be achieved.
2.27
5 yrs 6 m
1%
890.33 Crs
1% on or before 30D, Nil after 30D
Large Growth
7.74
SIP 100 & Lumpsum 1000
BSE HEALTH CARE - TRI
Dhaval Shah
Investors understand that their principal will be at very high risk